Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

RYZB

RayzeBio (RYZB)

RayzeBio Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:RYZB
DateHeureSourceTitreSymboleSociété
07/03/202422h07Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:RYZBRayzeBio Inc
27/02/202422h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYZBRayzeBio Inc
26/02/202415h20Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RYZBRayzeBio Inc
26/02/202415h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RYZBRayzeBio Inc
23/02/202413h53Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:RYZBRayzeBio Inc
23/02/202412h59Business WireBristol Myers Squibb Announces Expiration of RayzeBio Tender OfferNASDAQ:RYZBRayzeBio Inc
12/02/202412h59Business WireBristol Myers Squibb and RayzeBio Announce Expiration of HSR Act Waiting PeriodNASDAQ:RYZBRayzeBio Inc
25/01/202414h53Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:RYZBRayzeBio Inc
08/01/202416h06PR Newswire (US)Kuehn Law Encourages KRTX, DSKE, RYZB, and GRCL Investors to Contact Law FirmNASDAQ:RYZBRayzeBio Inc
27/12/202322h15Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:RYZBRayzeBio Inc
26/12/202316h28Dow Jones NewsTrending: Bristol Myers Squibb to Buy RayzeBioNASDAQ:RYZBRayzeBio Inc
26/12/202314h04Dow Jones NewsRayzeBio Shares Soar Premarket on Takeover by Bristol MyersNASDAQ:RYZBRayzeBio Inc
26/12/202313h46Dow Jones NewsBristol Myers Squibb to Buy RayzeBio for $4.1 BillionNASDAQ:RYZBRayzeBio Inc
26/12/202313h13GlobeNewswire Inc.Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBioNASDAQ:RYZBRayzeBio Inc
26/12/202312h59Business Wire Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBioNASDAQ:RYZBRayzeBio Inc
13/11/202322h04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RYZBRayzeBio Inc
13/11/202322h01GlobeNewswire Inc.RayzeBio Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:RYZBRayzeBio Inc
06/11/202322h05GlobeNewswire Inc.RayzeBio to Participate in Upcoming Investor Conferences in November 2023NASDAQ:RYZBRayzeBio Inc
01/11/202311h00GlobeNewswire Inc.RayzeBio Appoints Industry Leader Tim Van Hauwermeiren to Its Board of DirectorsNASDAQ:RYZBRayzeBio Inc
24/10/202314h00GlobeNewswire Inc.FDA selects RayzeBio to Participate in the Inaugural CDRP Program to Expedite Commercial Manufacturing Readiness for RYZ101 in GEP-NETsNASDAQ:RYZBRayzeBio Inc
18/10/202313h00GlobeNewswire Inc.RayzeBio to Present at European Society for Medical Oncology (ESMO) CongressNASDAQ:RYZBRayzeBio Inc
20/09/202300h51KR Market News인스타카트, 나스닥 데뷔로 주가는 12% 상승NASDAQ:RYZBRayzeBio Inc
19/09/202322h01Business WireRayzeBio, Inc. Announces Closing of Upsized $358 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:RYZBRayzeBio Inc
 Showing the most relevant articles for your search:NASDAQ:RYZB